CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.64M | 8.55M | 5.49M | 3.19M | 879.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.64M | 8.55M | 5.49M | 3.19M | 879.30K |
| Cost of Revenue | 5.76M | 4.59M | 3.44M | 2.05M | 655.00K |
| Gross Profit | 5.88M | 3.96M | 2.05M | 1.14M | 224.20K |
| SG&A Expenses | 15.95M | 19.26M | 22.63M | 22.38M | 22.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 19.91M | 19.71M | 19.50M | 9.76M | -19.60K |
| Total Operating Expenses | 90.10M | 99.93M | 110.03M | 106.71M | 103.14M |
| Operating Income | -78.47M | -91.38M | -104.54M | -103.52M | -102.26M |
| Income Before Tax | -72.59M | -91.65M | -110.94M | -103.67M | -96.18M |
| Income Tax Expenses | 48.30K | 48.30K | 48.30K | 52.40K | 56.30K |
| Earnings from Continuing Operations | -72.64 | -91.69 | -110.99 | -103.72 | -96.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.64M | -91.69M | -110.99M | -103.72M | -96.23M |
| EBIT | -78.47M | -91.38M | -104.54M | -103.52M | -102.26M |
| EBITDA | -69.87M | -82.57M | -95.49M | -94.23M | -92.76M |
| EPS Basic | -0.13 | -0.17 | -0.20 | -0.19 | -0.17 |
| Normalized Basic EPS | -0.08 | -0.10 | -0.13 | -0.12 | -0.11 |
| EPS Diluted | -0.13 | -0.17 | -0.20 | -0.19 | -0.17 |
| Normalized Diluted EPS | -0.08 | -0.10 | -0.13 | -0.12 | -0.11 |
| Average Basic Shares Outstanding | 2.20B | 2.21B | 2.21B | 2.22B | 2.23B |
| Average Diluted Shares Outstanding | 2.20B | 2.21B | 2.21B | 2.22B | 2.23B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |